StonvexLoading…
StonvexStonvexStonvexCore line items from IOVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $71.43M | $263.50M | $176.73M | $109.28M |
Operating Income | $-81.04M | $-403.36M | $-329.90M | $-235.00M |
Net Income | $-79.05M | $-390.98M | $-319.07M | $-227.82M |
EPS (Diluted) | $-0.19 | $-1.09 | $-0.94 | $-0.69 |
Total Assets | $925.66M | $913.17M | $904.95M | $907.44M |
Total Liabilities | $203.91M | $214.59M | $202.66M | $208.95M |
Cash & Equivalents | $196.51M | $163.08M | $158.13M | $132.47M |
Free Cash Flow OCF − CapEx | $-78.68M | $-336.24M | $-274.36M | $-184.81M |
Shares Outstanding | 438.11M | 411.94M | 385.46M | 341.92M |